CX Institutional’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CX Institutional’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$52K	Buy	+328	New	+$51.8K	﹤0.01%	1009
2026 Q2	–	Sell	-4,040	Closed	-$516K	–	1643
2026 Q1	$516K	Hold	4,040	–	–	0.02%	455
2025 Q4	$493K	Sell	4,040 -8,160	-67%	-$936K	0.01%	423
2025 Q3	$1.22M	Buy	12,200 +4	+0%	+$360	0.04%	268
2025 Q2	$1.01M	Hold	12,196	–	–	0.04%	267
2025 Q1	$989K	Hold	12,196	–	–	0.04%	272
2024 Q4	$1.1M	Buy	12,196 +196	+2%	+$19K	0.04%	243
2024 Q3	$1.19M	Hold	12,000	–	–	0.05%	262
2024 Q2	$1.11M	Hold	12,000	–	–	0.05%	267
2024 Q1	$1.14M	Hold	12,000	–	–	0.05%	265
2023 Q4	$1.07M	Hold	12,000	–	–	0.06%	248
2023 Q3	$876K	Hold	12,000	–	–	0.05%	268
2023 Q2	$998K	Sell	12,000 -350	-3%	-$29.3K	0.05%	279
2023 Q1	$952K	Hold	12,350	–	–	0.05%	280
2022 Q4	$1.03M	Hold	12,350	–	–	0.06%	273
2022 Q3	$980K	Sell	12,350 -166	-1%	-$14K	0.07%	266
2022 Q2	$929K	Buy	12,516 +166	+1%	+$12.5K	0.07%	248
2022 Q1	$1.11M	Hold	12,350	–	–	0.09%	208
2021 Q4	$1.38M	Hold	12,350	–	–	0.11%	176
2021 Q3	$1.55M	Hold	12,350	–	–	0.13%	174
2021 Q2	$1.67M	Hold	12,350	–	–	0.14%	172
2021 Q1	$1.68M	Hold	12,350	–	–	0.15%	169
2020 Q4	$1.74M	Hold	12,350	–	–	0.17%	165
2020 Q3	$1.38M	Buy	12,350 +350	+3%	+$39.2K	0.15%	159
2020 Q2	$1.34M	Hold	12,000	–	–	0.18%	136
2020 Q1	$929K	Hold	12,000	–	–	0.15%	138
2019 Q4	$1.14M	Hold	12,000	–	–	0.2%	105
2019 Q3	$915K	Hold	12,000	–	–	0.15%	136
2019 Q2	$1.05M	Hold	12,000	–	–	0.17%	125
2019 Q1	$1.09M	Hold	12,000	–	–	0.19%	123
2018 Q4	$861K	Buy	+12,000	New	+$967K	0.18%	97

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Madrona Financial Services Everett, Washington $646M AUM 23.24% 1-Year Est. Return

Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

CX Institutional's XBI Position: Q3 2026 in Review

CX Institutional opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 328 shares worth $52K. The stake represents ﹤0.01% of the portfolio and ranks #1009 among its holdings. This is a return to the name: CX Institutional previously reported a position in XBI as recently as Q1 2026.

CX Institutional first reported a position in XBI in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.74M in Q4 2020. 261 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

CX Institutional held 328 shares of State Street SPDR S&P Biotech ETF worth $52K as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new CX Institutional position in Q3 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1009 holding.
CX Institutional first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 31 quarters since.
CX Institutional's State Street SPDR S&P Biotech ETF position peaked at $1.74M in Q4 2020.
261 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.